U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Aralast
  1. Approved Blood Products

STN: 125039
Proper Name: Alpha-1-Proteinase Inhibitor (Human)
Tradename: Aralast
Manufacturer: Baxter Healthcare Corp, License #014
Indication: 

  • For augmentation therapy in patients having congenital deficiency of alpha-1-proteinase inhibitor with clinically evident emphysema.

Product Information

Supporting Documents


Related Information

  • FDA Online Label Repository
    Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.
Back to Top